Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor

Author： Osorio Juan C. Cheema Faisal H. Martens Timothy P. Mahmut Naila Kinnear Caroline Gonzalez Ana M.D. Bonney William Homma Shunichi Liao James K. Mital Seema

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.86, Iss.9, 2008-09, pp. : 633-642

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

p38 stress-activated protein kinase inhibitor reverses bradykinin B 1 receptor-mediated component of inflammatory hyperalgesia

By Ganju P. Davis A. Patel S. Nunez X. Fox A.

European Journal of Pharmacology, Vol. 421, Iss. 3, 2001-06 ,pp. : 191-199

Elsevier

Access to resources Recommend Favorite

BW373U86, a -opioid receptor agonist, reverses bradykinin-induced thermal allodynia in rhesus monkeys

By Butelman E.R. Negus S.S. Gatch M.B. Chang K.-J. Woods J.H.

European Journal of Pharmacology, Vol. 277, Iss. 2, 1995-04 ,pp. : 285-287

Elsevier

Access to resources Recommend Favorite

Targeting the ‘Janus face' of the B2-bradykinin receptor

By Blaes Nelly Girolami Jean-Pierre

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 10, 2013-10 ,pp. : 1145-1166

Informa Healthcare

Access to resources Recommend Favorite

Bradykinin-induced knee joint incapacitation involves bradykinin B 2 receptor mediated hyperalgesia and bradykinin B 1 receptor-mediated nociception

By Tonussi C.R. Ferreira S.H.

European Journal of Pharmacology, Vol. 326, Iss. 1, 1997-05 ,pp. : 61-65

Elsevier

Access to resources Recommend Favorite

A central role of EGF receptor transactivation in angiotensin II -induced cardiac hypertrophy

By Shah B.H. Catt K.J.

Trends in Pharmacological Sciences, Vol. 24, Iss. 5, 2003-05 ,pp. : 239-244

Elsevier

Access to resources Recommend Favorite